• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYNOSURE LUTRONIC TECHNOLOGY CORPORATION CLARITY II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYNOSURE LUTRONIC TECHNOLOGY CORPORATION CLARITY II Back to Search Results
Catalog Number 1110200210
Medical Device Problem Code Environmental Particulates (2930)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/11/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Cynosure lutronic technology (clt) clinical team contacted the site to investigate the event.Clt clinical confirmed no injuries had occurred.Parameters used were within published guidelines, including icd at 10/10/10.Device evaluation was not performed since spark and soot observation is a known occurrence.Cryogen is applied to the treatment site during vascular treatment to precool the skin.The cryogen begins to vaporize from the surface of the skin shortly after contact.The laser fires onto the surface of the skin after a delay time.The spark/ignition events occur when residual cryogen vapors remaining on the skin surface interact with the high-energy 1064 nm laser fluence.Longer pre-cooling and delay times increase the likelihood of uneven vapor accumulation, thereby elevating the risk of ignition.This can be observed as a spark and can result in topical burn.To reduce the probability of reoccurrence the treatment provider was informed that vascular lesion treatments over 60 j/cm2 should utilize an icd setting of 10/10/10 per the recent update.A customer letter has since gone out to notify customers of this recommended setting update.Implementation of the updated recommended settings is intended to reduce the likelihood of reoccurrence; however, the spark and soot condition has not been fully eliminated and continues to occur.As such, the event continues to be assessed and reported as a device malfunction.The event is reportable per fda medical device reporting title 21 cfr part 803 since an observed malfunction occurred and could likely cause or contribute to a serious injury if the malfunction were to recur.
 
Event or Problem Description
It was reported that spark and soot occurred during a leg vessel treatment using clarity ii.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLARITY II
Common Device Name
CLARITY II
Manufacturer (Section D)
CYNOSURE LUTRONIC TECHNOLOGY CORPORATION
219 sowon-ro
deogyang-gu, goyang-si 10534
KS  10534
Manufacturer (Section G)
CYNOSURE LUTRONIC TECHNOLOGY CORPORATION
219 sowon-ro
deogyang-gu, goyang-si 10534
KS   10534
Manufacturer Contact
nirav desai
5 carlisle road
westford, MA 01886
MDR Report Key25437847
Report Number3021199089-2026-00039
Device Sequence Number16042087
Product Code GEX
UDI-Device Identifier08800291820040
UDI-Public(01)08800291820040(11)250220
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K183566
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Consumer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 06/08/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number1110200210
Was Device Available for Evaluation? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/11/2026
Initial Report FDA Received Date06/08/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexFemale
-
-